Catheter precision, inc. announces effectiveness of 1-for-19 reverse stock split

Fort mills, s.c., aug. 15, 2025 (globe newswire) -- catheter precision, inc. (nyse american:   vtak), a us based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that its previously announced 1-for-19 reverse stock split of its common stock became effective at 12:01 a.m. eastern time, on august 15, 2025. the company's common stock will continue to be traded on the nyse american under the symbol "vtak" and will begin trading on a split-adjusted basis when the market opens on august 15, 2025. the new cusip number for the company's common stock following the reverse stock split will be 74933x708.
VTAK Ratings Summary
VTAK Quant Ranking